(Q34636336)

English

Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

multicenter clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Masazumi Okajima

14

object named as

Masazumi Okajima

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ichinosuke Hyodo

15

object named as

Ichinosuke Hyodo

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Megumi Ishiguro

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kenjiro Kotake

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Genichi Nishimura

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Naohiro Tomita

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Wataru Ichikawa

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Keiichi Takahashi

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Toshiaki Watanabe

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tomohisa Furuhata

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ken Kondo

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Masaki Mori

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yoshihiro Kakeji

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Akiyoshi Kanazawa

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Michiya Kobayashi

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Keiko Miyakoda

16

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kenichi Sugihara

17

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

25 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

149

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

7 July 2018

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

7 July 2018

A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

7 July 2018

Capecitabine as adjuvant treatment for stage III colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

7 July 2018

The epidermal growth factor receptor as a target for colorectal cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

7 July 2018

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

7 July 2018

Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

7 July 2018

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

7 July 2018

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

7 July 2018

The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

7 July 2018

Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

7 July 2018

Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

7 July 2018

Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-149

21 January 2018

Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

26 October 2018

High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618253

26 October 2018

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

1 reference

https://pubmed.ncbi.nlm.nih.gov/23530572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/23530572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23530572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23530572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/23530572

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-13-149

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34636336&oldid=2196900053"